Antiviral agent
AssigneesViktor Veniaminovich Tets, Georgy Viktorovich Tets
InventorRimma Ilinichna Ashkinazi
Life of this patent
Estimating the term…
Abstract
The invention relates to antiviral agents and specifically to synthetic biologically-active derivatives, and can be used in the pharmaceutical industry, in medicine, in plant husbandry and in biotechnology. The antiviral agent is based on poly-N1-hydrazino(imino)methyl-1,6-hexanediamine-poly-N1-amino(imino)methyl-1,6-hexane diamine of general formula (1), where: HX is an acid, n=3-20, and m=4-20, and which is active against viruses of humans, animals, plants, bacteria and fungi, said viruses being non-enveloped and enveloped and containing RNA or DNA. The antiviral agent exhibits a broad range of effectiveness, and is active against viruses both in intracellular and extracellular locations.
Claims20
A method of treating a viral infection in a subject in need thereof, the method comprising administering to the subject an effective amount of a compound comprising the structure
- or a pharmaceutically acceptable salt thereof, wherein HX is an acid;
- n is 3-20;
- and m is 4-20.
A method of inhibiting a virus, comprising contacting the virus with an effective amount of a compound comprising the structure
- or a pharmaceutically acceptable salt thereof, wherein HX is an acid;
- n is 3-20;
- and m is 4-20.
A method of treating a viral infection in a subject in need thereof, the method comprising administering to the subject an effective amount of an antiviral agent, the antiviral agent consisting essentially of the compound
- or a pharmaceutically acceptable salt thereof, wherein HX is an acid;
- n is 3-20;
- and m is 4-20.
Dependencies are inferred from the claim text.